// App-Quantinova.ai

242 : Baseline characteristics of patients with lupus nephritis requiring rituximab therapy: results from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR)

Researchers

Presenter

  • Sophie Collinson

Principal Investigators

  • Eoghan M McCarthy

  • Emily Sutton

  • David Jayne

  • Bridget Griffiths

  • David A Isenberg

  • Anisur Rahman

  • Caroline Gordon

  • David P DCruz

  • Peter Hewins

  • Benjamin Rhodes

  • Peter Lanyon

  • Edward M Vital

  • Chee-Seng Yee

  • Christopher J Edwards

  • Lee-Suan Teh

  • Mohammed Akil

  • Neil J McHugh

  • Asad Zoma

  • Ian N Bruce

Medical Centers

  • Kellgren Centre for Rheumatology, NIHR Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UNITED KINGDOM

  • Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UNITED KINGDOM

  • Department of Clinical Immunology, Box 109, Addenbrooke’s Hospital, Cambridge, UNITED KINGDOM

  • Rheumatology, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UNITED KINGDOM

  • Centre for Rheumatology, Department of Medicine, University College London, UK

  • Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UNITED KINGDOM

  • Louise Coote Lupus Unit, Guy's Hospital, London, UNITED KINGDOM

  • Department of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UNITED KINGDOM

  • Department of Renal Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UNITED KINGDOM

  • Department of Rheumatology, Queens Medical Centre, Nottingham, UNITED KINGDOM

  • NIHR- Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust

  • Department of Haematology, Doncaster and Bassetlaw Hospitals NHS Foundation Trust, Doncaster

  • Musculoskeletal Research Unit, NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton, Southampton, UK

  • Department of Rheumatology, University Hospital Southampton NHS Foundation Trust, Southampton, UNITED KINGDOM

  • Rheumatology, Royal Blackburn Hospital, Blackburn, UNITED KINGDOM

  • Rheumatology Department, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom

  • Department of Rheumatology, Royal National Hospital for Rheumatic Diseases NHS Foundation Trust, Bath, UNITED KINGDOM

  • Department of Pharmacy and Pharmacology, University of Bath, Bath, UNITED KINGDOM

  • Rheumatology Department, Hairmyres Hospital, Lancashire, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Nephrology

Disease

  • Lupus nephritis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GlaxoSmithKline (GSK)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved